BioCentury | Nov 13, 2019
Finance

Conjugate company Avidity preps for first dystrophy study with $100M series C

...were new investors Cormorant Asset Management, CureDuchenne, Logos Capital, Partner Fund Management, Perceptive Advisors and ST Pharm...
Items per page:
1 - 1 of 1
BioCentury | Nov 13, 2019
Finance

Conjugate company Avidity preps for first dystrophy study with $100M series C

...were new investors Cormorant Asset Management, CureDuchenne, Logos Capital, Partner Fund Management, Perceptive Advisors and ST Pharm...
Items per page:
1 - 1 of 1